1
|
Nilsson L and Rybo G: Treatment of
menorrhagia. Am J Obstet Gynecol. 110:713–720. 1971.PubMed/NCBI
|
2
|
Maresh MJ, Metcalfe MA, McPherson K,
Overton C, Hall V, Hargreaves J, Bridgman S, Dobbins J and Casbard
A: The VALUE national hysterectomy study: Description of the
patients and their surgery. BJOG. 109:302–312. 2002. View Article : Google Scholar : PubMed/NCBI
|
3
|
Stovall DW: Alternatives to hysterectomy:
Focus on global endometrial ablation, uterine fibroid embolization,
and magnetic resonance-guided focused ultrasound. Menopause.
18:437–444. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Middleton LJ, Champaneria R, Daniels JP,
Bhattacharya S, Cooper KG, Hilken NH, O'Donovan P, Gannon M, Gray
R, Khan KS, et al: International Heavy Menstrual Bleeding
Individual Patient Data Meta-analysis Collaborative Group:
Hysterectomy, endometrial destruction, and levonorgestrel releasing
intrauterine system (Mirena) for heavy menstrual bleeding:
Systematic review and meta-analysis of data from individual
patients. BMJ. 341:c39292010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Neuwirth RS, Duran AA, Singer A, MacDonald
R and Bolduc L: The endometrial ablator: A new instrument. Obstet
Gynecol. 83:792–796. 1994.PubMed/NCBI
|
6
|
Loffer FD: Three-year comparison of
thermal balloon and rollerball ablation in treatment of
menorrhagia. J Am Assoc Gynecol Laparosc. 8:48–54. 2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Shaw RW, Symonds IM, Tamizian O, Chaplain
J and Mukhopadhyay S: Randomised comparative trial of thermal
balloon ablation and levonorgestrel intrauterine system in patients
with idiopathic menorrhagia. Aust N Z J Obstet Gynaecol.
47:335–340. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li M, Kang JL, Ji YQ, Liu HF, Nie ML and
Wang XX: Effect of levonorgestrel-releasing intrauterine system and
thermal balloon ablation for the treatment of heavy menstrual
bleeding. Bei Jing Da Xue Zhong Gyo Fu Chan Ke Lin Chuang Za Zhi.
6:501–505. 2013.(In Chinese).
|
9
|
Busfield RA, Farquhar CM, Sowter MC,
Lethaby A, Sprecher M, Yu Y, Sadler LC, Brown P and Johnson N: A
randomised trial comparing the levonorgestrel intrauterine system
and thermal balloon ablation for heavy menstrual bleeding. BJOG.
113:257–263. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
de Souza SS, Camargos AF, de Rezende CP,
Pereira FA, Araújo CA and Filho AL Silva: A randomized prospective
trial comparing the levonorgestrel-releasing intrauterine system
with thermal balloon ablation for the treatment of heavy menstrual
bleeding. Contraception. 81:226–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Barrington JW, Arunkalaivanan AS and
Abdel-Fattah M: Comparison between the levonorgestrel intrauterine
system (LNG-IUS) and thermal balloon ablation in the treatment of
menorrhagia. Eur J Obstet Gynecol Reprod Biol. 108:72–74. 2003.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Soysal M, Soysal S and Ozer S: A
randomized controlled trial of levonorgestrel releasing IUD and
thermal balloon ablation in the treatment of menorrhagia. Zentralbl
Gynakol. 124:213–219. 2002. View Article : Google Scholar : PubMed/NCBI
|
13
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group: Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA statement. Ann Intern Med.
151:264–269. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Atkins D, Best D, Briss PA, Eccles M,
Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry
D, et al: GRADE Working Group: Grading quality of evidence and
strength of recommendations. BMJ. 328:14902004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hays RD, Sherbourne CD and Mazel RM: The
RAND 36-Item Health Survey 1.0. Health Econ. 2:217–227. 1993.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Higgins JPT and Green S: Cochrane Handbook
for Systematic Reviews of Interventions (Version. 5.1.0). The
Cochrane Collaboration; Oxford, England: 2011, http://handbook.cochrane.orgAccessed. Dec
30–2012
|
17
|
Brown PM, Farquhar CM, Lethaby A, Sadler
LC and Johnson NP: Cost-effectiveness analysis of levonorgestrel
intrauterine system and thermal balloon ablation for heavy
menstrual bleeding. BJOG. 113:797–803. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Tam WH, Yuen PM, Ng DP Shan, Leung PL, Lok
IH and Rogers MS: Health status function after treatment with
thermal balloon endometrial ablation and levonorgestrel
intrauterine system for idiopathic menorrhagia: A randomized study.
Gynecol Obstet Invest. 62:84–88. 2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kim JY, No JH, Kim K, Kim YB, Jee BC, Lee
JR and Suh CS: Effect of myoma size on failure of thermal balloon
ablation or levonorgestrel releasing intrauterine system treatment
in women with menorrhagia. Obstet Gynecol Sci. 56:36–40. 2013.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Silva-Filho AL, Fde A Pereira, de Souza
SS, Loures LF, Rocha AP, Valadares CN, Carneiro MM, Tavares RL and
Camargos AF: Five-year follow-up of levonorgestrel-releasing
intrauterine system versus thermal balloon ablation for the
treatment of heavy menstrual bleeding: a randomized controlled
trial. Contraception. 87:409–415. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Herman MC, van den Brink MJ, Geomini PM,
van Meurs HS, Huirne JA, Eising HP, Timmermans A, Pijnenborg JM,
Klinkert ER, Coppus SF, et al: Levonorgestrel releasing
intrauterine system (Mirena) versus endometrial ablation (Novasure)
in women with heavy menstrual bleeding: A multicentre randomised
controlled trial. BMC Womens Health. 13:322013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Barnard K, Frayne SM, Skinner KM and
Sullivan LM: Health status among women with menstrual symptoms. J
Womens Health (Larchmt). 12:911–919. 2003. View Article : Google Scholar : PubMed/NCBI
|
23
|
Frick KD, Clark MA, Steinwachs DM,
Langenberg P, Stovall D, Munro MG and Dickersin K: STOP-DUB
Research Group: Financial and quality-of-life burden of
dysfunctional uterine bleeding among women agreeing to obtain
surgical treatment. Womens Health Issues. 19:70–78. 2009.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Kӧchli OR: Endometrial ablation in the
year 2000 - do we have more methods than indications? Contrib
Gynecol Obstet. 20:91–120. 2000. View Article : Google Scholar : PubMed/NCBI
|
25
|
Sowter MC: New surgical treatments for
menorrhagia. Lancet. 361:1456–1458. 2003. View Article : Google Scholar : PubMed/NCBI
|
26
|
Grainger DA, Tjaden BL, Rowland C and
Meyer WR: Thermal balloon and rollerball ablation to treat
menorrhagia: Two-year results of a multicenter, prospective,
randomized, clinical trial. J Am Assoc Gynecol Laparosc. 7:175–179.
2000. View Article : Google Scholar : PubMed/NCBI
|
27
|
Andersson JK and Rybo G:
Levonorgestrel-releasing intrauterine device in the treatment of
menorrhagia. Br J Obstet Gynaecol. 97:690–694. 1990. View Article : Google Scholar : PubMed/NCBI
|
28
|
Hurskainen R, Teperi J, Rissanen P, Aalto
AM, Grenman S, Kivelä A, Kujansuu E, Vuorma S, Yliskoski M and
Paavonen J: Clinical outcomes and costs with the
levonorgestrel-releasing intrauterine system or hysterectomy for
treatment of menorrhagia: Randomized trial 5-year follow-up. JAMA.
291:1456–1463. 2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
Stewart A, Cummins C, Gold L, Jordan R and
Phillips W: The effectiveness of the levonorgestrel-releasing
intrauterine system in menorrhagia: A systematic review. BJOG.
108:74–86. 2001. View Article : Google Scholar : PubMed/NCBI
|